Metformin for Treatment of Acute COVID-19: Systematic Review of Clinical Trial Data Against SARS-CoV-2
出版年份 2023 全文链接
标题
Metformin for Treatment of Acute COVID-19: Systematic Review of Clinical Trial Data Against SARS-CoV-2
作者
关键词
-
出版物
DIABETES CARE
Volume 46, Issue 7, Pages 1432-1442
出版商
American Diabetes Association
发表日期
2023-06-21
DOI
10.2337/dc22-2539
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1
- (2022) Xiao Sun et al. CELL DEATH AND DIFFERENTIATION
- Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy
- (2022) Azizul Haque et al. JOURNAL OF AUTOIMMUNITY
- Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
- (2022) Abira Usman et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Patients with Obesity and a History of Metformin Treatment Have Lower Influenza Mortality: A Retrospective Cohort Study
- (2022) Tammy H. Cummings et al. Pathogens
- Treatment with metformin glycinate reduces SARS-CoV-2 viral load: an in vitro model and randomized, double-blind, Phase IIb clinical trial
- (2022) Claudia Ventura-López et al. BIOMEDICINE & PHARMACOTHERAPY
- Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
- (2022) Baoqi Zeng et al. BMC Medicine
- Protection by metformin against severe Covid-19: an in-depth mechanistic analysis
- (2022) Nicolas Wiernsperger et al. DIABETES & METABOLISM
- Metformin: Is it a drug for all reasons and diseases?
- (2022) Chris R. Triggle et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus
- (2022) Zhiyuan Ma et al. Scientific Reports
- Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin
- (2022) Clifford J. Bailey et al. Frontiers in Pharmacology
- Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
- (2022) Carolyn T. Bramante et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting T cell (oxidative) metabolism to improve immunity to viral infection in the context of obesity
- (2022) Elizabeth Greene et al. Frontiers in Immunology
- The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes
- (2022) Maria Mercado-Gómez et al. Communications Biology
- Metformin is associated with reduced COVID-19 severity in patients with prediabetes
- (2022) Lauren E. Chan et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study
- (2022) Carolyn T. Bramante et al. PLoS One
- Metformin suppresses SARS-CoV-2 in cell culture
- (2022) Haripriya Parthasarathy et al. VIRUS RESEARCH
- COVID-19 vaccine diplomacy and equitable access to vaccines amid ongoing pandemic
- (2021) Khan Sharun et al. ARCHIVES OF MEDICAL RESEARCH
- The antiviral effect of metformin on zika and dengue virus infection
- (2021) Carlos Noe Farfan-Morales et al. Scientific Reports
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation
- (2021) Hongxu Xian et al. IMMUNITY
- Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit
- (2021) Sherehan Ibrahim et al. Frontiers in Endocrinology
- Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses
- (2021) Matthew A. Schaller et al. JCI Insight
- Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis
- (2021) Yin Li et al. Frontiers in Medicine
- Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential
- (2021) Olexandr Kamyshnyi et al. BIOMEDICINE & PHARMACOTHERAPY
- Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1
- (2021) Theodore J. Cory et al. Frontiers in Immunology
- Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
- (2020) Mhairi Campbell et al. BMJ-British Medical Journal
- Benefits of Metformin in Attenuating the Hallmarks of Aging
- (2020) Ameya S. Kulkarni et al. Cell Metabolism
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin
- (2020) Jamie N. Justice et al. GeroScience
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Anti-Inflammatory Effects of Metformin Irrespective of Diabetes StatusNovelty and Significance
- (2016) Amy R. Cameron et al. CIRCULATION RESEARCH
- The Primary Outcome Fails — What Next?
- (2016) Stuart J. Pocock et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation. Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
- (2015) John B. Buse et al. DIABETES CARE
- OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects
- (2010) J. M. Moreno-Navarrete et al. DIABETES
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started